Dopaminergic News and Research

RSS

SRY gene directly controls neuronal function in the brain

Shaped by much previous research, the prevailing view regarding sex-specific differences in the brain is that they are caused by circulating sex hormones, which are generated outside the brain and influence certain aspects of brain development, as well as brain function in adults.

23 Feb 2006

Animal model of Parkinson's disease reveals striking sensitivity to common environmental toxins

In findings that support a relationship between agricultural chemicals and Parkinson's disease, two groups of researchers have found new evidence that loss of DJ-1, a gene known to be linked to inherited Parkinson's disease, leads to striking sensitivity to the herbicide paraquat and the insecticide rotenone.

7 Sep 2005

Rotenone study may lead to novel therapies for Parkinson's disease

Neuroscientists from the University at Buffalo have described for the first time how rotenone, an environmental toxin linked specifically to Parkinson's disease, selectively destroys the neurons that produce dopamine, the neurotransmitter critical to body movement and muscle control.

23 Aug 2005

A protein found naturally in the brain may protect against Parkinson's disease

The findings also may lead to an improved understanding of a disorder called early-onset torsion dystonia.

2 Jun 2005

Findings could lead to improved treatments for schizophrenics, amphetamine abusers

An Oregon Health & Science University researcher is among an international team closing in on why many people with schizophrenia and other psychotic disorders are "supersensitive" to the powerful neurotransmitter dopamine.

10 Apr 2005

Body's 'internal marijuana': A new target for treatment of schizophrenia, Parkinson's?

“Endocannabinoids” is an impressive word that sounds like the name for a group of tribal warriors or an ancient people. Actually, it is the scientific term for beneficial molecules produced in the brain that act as “a sort of internal marijuana in our system

4 Nov 2004

Evidence links cellular iron deficiency to restless legs syndrome

Iron-deficient cells in the brain are mixing up central nervous system signals to the legs and arms causing the irresistible urges to move and creepy-crawly sensations that characterize restless legs syndrome (RLS), a Penn State College of Medicine study reports.

25 Oct 2004

Stem cells and drug design

Victorian College of Pharmacy researchers hope stem cells will help them better understand the action of existing drugs and aid in the discovery of new drugs for illnesses such as depression, obesity and anxiety.

5 Oct 2004

Investigating how young adults with attention deficit hyperactivity disorder process sound

Mary-Claire Hanlon, a Psychology Honours student at the University of Newcastle under the supervision of Dr Frini Karayanidis and Associate Professor Ulrich Schall, is recruiting participants for the study investigating the role of sound and dopaminergic mechanisms (brain chemicals) in people with ADHD.

12 Aug 2004

Clinical study compares treatments in early Parkinson's disease

University of Tennessee Health Science Center professor and vice chair of the Department of Neurology, Ronald F. Pfeiffer, M.D., has been an investigator with The Parkinson Study Group (PSG), which recently reported four-year results of a major long-term, multi-center clinical trial.

21 Jul 2004

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

An article in the July issue of the Archives of Neurology reports that the drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects.

20 Jul 2004

Dopaminergic News and Research

SRY gene directly controls neuronal function in the brain

Animal model of Parkinson's disease reveals striking sensitivity to common environmental toxins

Rotenone study may lead to novel therapies for Parkinson's disease

A protein found naturally in the brain may protect against Parkinson's disease

Findings could lead to improved treatments for schizophrenics, amphetamine abusers

Body's 'internal marijuana': A new target for treatment of schizophrenia, Parkinson's?

Evidence links cellular iron deficiency to restless legs syndrome

Stem cells and drug design

Investigating how young adults with attention deficit hyperactivity disorder process sound

Clinical study compares treatments in early Parkinson's disease

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

Michael J. Fox Foundation funds $2 million to solve midbrain system mysteries

Significant vaccine advance for Parkinson’s disease therapy

Tooth cells may help treat Parkinson's disease

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News